| Product NDC: | 47335-779 |
| Proprietary Name: | Azelastine Hydrochloride |
| Non Proprietary Name: | Azelastine Hydrochloride |
| Active Ingredient(s): | 137 ug/1 & nbsp; Azelastine Hydrochloride |
| Administration Route(s): | NASAL |
| Dosage Form(s): | SPRAY, METERED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 47335-779 |
| Labeler Name: | Sun Pharma Global FZE |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090423 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120524 |
| Package NDC: | 47335-779-91 |
| Package Description: | 1 BOTTLE, SPRAY in 1 BOX (47335-779-91) > 200 SPRAY, METERED in 1 BOTTLE, SPRAY |
| NDC Code | 47335-779-91 |
| Proprietary Name | Azelastine Hydrochloride |
| Package Description | 1 BOTTLE, SPRAY in 1 BOX (47335-779-91) > 200 SPRAY, METERED in 1 BOTTLE, SPRAY |
| Product NDC | 47335-779 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Azelastine Hydrochloride |
| Dosage Form Name | SPRAY, METERED |
| Route Name | NASAL |
| Start Marketing Date | 20120524 |
| Marketing Category Name | ANDA |
| Labeler Name | Sun Pharma Global FZE |
| Substance Name | AZELASTINE HYDROCHLORIDE |
| Strength Number | 137 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] |